Related Experiment Video
Updated: May 24, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map
Anton G Kutikhin1, Arseniy E Yuzhalin
1Department of Epidemiology, Kemerovo State Medical Academy, Kemerovo, Russian Federation.
Abstract:
The group of pattern recognition receptors includes families of Toll-like receptors, NOD-like receptors, C-type lectin receptors, and RIG-I-like receptors. They are key sensors for a number of infectious agents, some of which are oncogenic, and they launch an immune response against them, normally promoting their eradication. Inherited variations in genes encoding these receptors and proteins and their signaling pathways may affect their function, possibly modulating cancer risk and features of cancer progression. There are numerous studies investigating the association of single nucleotide polymorphisms within or near genes encoding Toll-like receptors and NOD-like receptors, cancer risk, and features of cancer progression. However, there is an almost total absence of articles analyzing the correlation between polymorphisms of genes encoding C-type lectin receptors and RIG-I-like receptors and cancer risk or progression. Nevertheless, there is some evidence supporting the hypothesis that inherited C-type lectin receptor and RIG-I-like receptor variants can be associated with increased cancer risk. Certain C-type lectin receptors and RIG-I-like receptors recognize pathogen-associated molecular patterns of potentially oncogenic infectious agents, and certain polymorphisms of genes encoding C-type lectin receptors and RIG-I-like receptors may have functional consequences at the molecular level that can lead to association of such single nucleotide polymorphisms with risk or progression of some diseases that may modulate cancer risk, so these gene polymorphisms may affect cancer risk indirectly. Polymorphisms of genes encoding C-type lectin receptors and RIG-I-like receptors thereby may be correlated with a risk of lung, oral, esophageal, gastric, colorectal, and liver cancer, as well as nasopharyngeal carcinoma, glioblastoma, multiple myeloma, and lymphoma. The list of the most promising polymorphisms for oncogenomic investigations may include rs1926736, rs2478577, rs2437257, rs691005, rs2287886, rs735239, rs4804803, rs16910526, rs36055726, rs11795404, and rs10813831.
Insights
Genetic variations in C-type lectin receptors and RIG-I-like receptors may influence cancer risk. Further research is needed to understand the link between these pattern recognition receptor polymorphisms and cancer progression.
Area of Science:
- Immunology
- Oncology
- Genetics
Background:
- Pattern recognition receptors (PRRs) are crucial for detecting infectious agents, including oncogenic ones, and initiating immune responses.
- Inherited variations in PRR genes can impact immune function and potentially influence cancer risk and progression.
- While Toll-like receptors (TLRs) and NOD-like receptors (NLRs) have been studied, C-type lectin receptors (CLRs) and RIG-I-like receptors (RLRs) in relation to cancer remain under-investigated.
Purpose of the Study:
- To highlight the potential role of genetic polymorphisms in CLRs and RLRs in cancer risk and progression.
- To address the gap in research concerning CLR and RLR gene variations and their association with oncogenesis.
- To identify specific single nucleotide polymorphisms (SNPs) within CLR and RLR genes that warrant further investigation in cancer research.
Main Methods:
- Review of existing literature on PRRs, genetic variations, and cancer.
- Analysis of the functional consequences of CLR and RLR polymorphisms.
- Identification of candidate SNPs associated with various cancer types.
Main Results:
- Evidence suggests that inherited variations in CLRs and RLRs may be associated with increased cancer risk.
- Functional consequences of certain CLR and RLR polymorphisms can indirectly modulate cancer risk.
- Specific SNPs (e.g., rs1926736, rs2478577) are proposed as promising targets for oncogenomic studies.
Conclusions:
- Polymorphisms in CLR and RLR genes may correlate with the risk of developing various cancers, including lung, colorectal, and liver cancer.
- These genetic variations could influence cancer risk indirectly by affecting the recognition of oncogenic pathogens.
- Further research into CLR and RLR gene polymorphisms is essential for understanding their role in cancer development and progression.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
